These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1355 related articles for article (PubMed ID: 19251170)
1. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma. Watson TJ Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma. Zehetner J; DeMeester SR Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671 [TBL] [Abstract][Full Text] [Related]
3. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Barrett's esophagus with high-grade dysplasia. McAllaster JD; Buckles D; Al-Kasspooles M Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509 [TBL] [Abstract][Full Text] [Related]
5. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction]. von Rahden BH; Feith M; Stein HJ Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774 [TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Cameron AJ; Carpenter HA Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304 [TBL] [Abstract][Full Text] [Related]
7. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma. Gilbert S; Jobe BA Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Moss A; Bourke MJ; Hourigan LF; Gupta S; Williams SJ; Tran K; Swan MP; Hopper AD; Kwan V; Bailey AA Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694 [TBL] [Abstract][Full Text] [Related]
11. [Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer]. Bergman JJ; Marsman WA; Krishnadath KK; Fockens P; van Lanschot JJ; Tytgat GN Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2275-81. PubMed ID: 14655293 [TBL] [Abstract][Full Text] [Related]
12. Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus. DeMeester SR Semin Thorac Cardiovasc Surg; 2005; 17(4):320-5. PubMed ID: 16428038 [TBL] [Abstract][Full Text] [Related]
13. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Luna RA; Gilbert E; Hunter JG Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568 [TBL] [Abstract][Full Text] [Related]
14. Surgical management of Barrett's esophagus. Clark GW; DeMeester TR Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371 [TBL] [Abstract][Full Text] [Related]
16. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
17. Dysplasia in Barrett's esophagus: limitations of current management strategies. Spechler SJ Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042 [TBL] [Abstract][Full Text] [Related]
18. Current state of endoscopic therapies in Barrett's esophagus and esophageal cancer. Hudson M; Lin CL; Habr F Hosp Pract (1995); 2011 Feb; 39(1):170-80. PubMed ID: 21441773 [TBL] [Abstract][Full Text] [Related]
19. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia? Pech O; Ell C Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235 [TBL] [Abstract][Full Text] [Related]
20. Future developments in total Barrett's eradication: the surgeon's view. Watson TJ; Peters JH Endoscopy; 2008 Dec; 40(12):1048-51. PubMed ID: 19065490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]